We write to you to keep you informed of developments within the medial scheme industry that affect the funding of some tests, specifically BioFire, used for diagnosis in acute respiratory diseases, suspected meningitis/encephalitis and diarrhoeal disease for the rapid identification of the pathogenic cause.

Non-payment for Syndromic PCR testing (BioFire FilmArray)